These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 23499679)

  • 1. Chromone linked nitrone derivative induces the expression of iNOS2 and Th1 cytokines but reduces the Th2 response in experimental visceral leishmaniasis.
    Mallick S; Halder S; Dutta A; Dey S; Paul K; Maiti S; Bandyopadhyay C; Saha B; Pal C
    Int Immunopharmacol; 2013 Apr; 15(4):772-9. PubMed ID: 23499679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective therapy with novel chromone derivative against Leishmania donovani infection induces Th1 response in vivo.
    Mallick S; Dutta A; Ghosh J; Maiti S; Mandal AK; Banerjee R; Bandyopadhyay C; Pal C
    Chemotherapy; 2011; 57(5):388-93. PubMed ID: 22024637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quassin alters the immunological patterns of murine macrophages through generation of nitric oxide to exert antileishmanial activity.
    Bhattacharjee S; Gupta G; Bhattacharya P; Mukherjee A; Mujumdar SB; Pal A; Majumdar S
    J Antimicrob Chemother; 2009 Feb; 63(2):317-24. PubMed ID: 19036753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection.
    Bhattacharjee S; Bhattacharjee A; Majumder S; Majumdar SB; Majumdar S
    J Antimicrob Chemother; 2012 Aug; 67(8):1905-14. PubMed ID: 22589456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
    Mazumdar T; Anam K; Ali N
    Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection.
    Bimal S; Sinha S; Singh SK; Narayan S; Kumar V; Verma N; Ranjan A; Sinha PK; Das VN; Pandey K; Kar SK; Das P
    Exp Parasitol; 2012 Jul; 131(3):274-82. PubMed ID: 22580024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of Croton caudatus Geisel leaf extract against experimental visceral leishmaniasis induces proinflammatory cytokines in vitro and in vivo.
    Dey S; Mukherjee D; Chakraborty S; Mallick S; Dutta A; Ghosh J; Swapana N; Maiti S; Ghorai N; Singh CB; Pal C
    Exp Parasitol; 2015; 151-152():84-95. PubMed ID: 25655407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses.
    Gupta R; Kushawaha PK; Samant M; Jaiswal AK; Baharia RK; Dube A
    J Antimicrob Chemother; 2012 Feb; 67(2):440-3. PubMed ID: 22121191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
    Charan Raja MR; Velappan AB; Chellappan D; Debnath J; Kar Mahapatra S
    Eur J Med Chem; 2017 Oct; 139():503-518. PubMed ID: 28826085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
    Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
    Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
    Datta N; Mukherjee S; Das L; Das PK
    Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergic effect of eugenol oleate with amphotericin B augments anti-leishmanial immune response in experimental visceral leishmaniasis in vitro and in vivo.
    Kar A; Jayaraman A; Charan Raja MR; Srinivasan S; Debnath J; Mahapatra SK
    Int Immunopharmacol; 2021 Feb; 91():107291. PubMed ID: 33360084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis.
    Islamuddin M; Chouhan G; Want MY; Ozbak HA; Hemeg HA; Afrin F
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005011. PubMed ID: 27776125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asiaticoside induces tumour-necrosis-factor-α-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains.
    Bhaumik SK; Paul J; Naskar K; Karmakar S; De T
    J Antimicrob Chemother; 2012 Apr; 67(4):910-20. PubMed ID: 22258930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
    Vishwakarma P; Parmar N; Yadav PK; Chandrakar P; Kar S
    J Mol Med (Berl); 2016 Jun; 94(6):695-710. PubMed ID: 26830627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
    Choudhury R; Das P; De T; Chakraborti T
    Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.
    Paul J; Karmakar S; De T
    Eur J Immunol; 2012 Aug; 42(8):2087-99. PubMed ID: 22622993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
    Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
    Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antileishmanial and immunomodulatory activities of lupeol, a triterpene compound isolated from Sterculia villosa.
    Das A; Jawed JJ; Das MC; Sandhu P; De UC; Dinda B; Akhter Y; Bhattacharjee S
    Int J Antimicrob Agents; 2017 Oct; 50(4):512-522. PubMed ID: 28669838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXC chemokine-mediated protection against visceral leishmaniasis: involvement of the proinflammatory response.
    Gupta G; Bhattacharjee S; Bhattacharyya S; Bhattacharya P; Adhikari A; Mukherjee A; Bhattacharyya Majumdar S; Majumdar S
    J Infect Dis; 2009 Oct; 200(8):1300-10. PubMed ID: 19743920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.